American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …
Epidemiology of cancer-associated venous thrombosis
JF Timp, SK Braekkan, HH Versteeg… - Blood, The Journal …, 2013 - ashpublications.org
Cancer-associated venous thrombosis is a common condition, although the reported
incidence varies widely between studies depending on patient population, start and duration …
incidence varies widely between studies depending on patient population, start and duration …
Carbon dots as a potential therapeutic agent for the treatment of cancer‐related anemia
Due to the adverse effects of erythropoietin (EPO) on cancer patient survival, it is necessary
to develop new agents that can be used to efficiently manage and treat cancer‐related …
to develop new agents that can be used to efficiently manage and treat cancer‐related …
Mitigating acute chemotherapy-associated adverse events in patients with cancer
Despite the enthusiasm surrounding novel targeted agents and immunotherapies,
chemotherapy remains the mainstay treatment for most human malignancies, either alone or …
chemotherapy remains the mainstay treatment for most human malignancies, either alone or …
2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American …
The purpose of this focused update is to update the “2013 ACCF/AHA Guideline for the
Management of Heart Failure” 9 (2013 HF guideline) in areas in which new evidence has …
Management of Heart Failure” 9 (2013 HF guideline) in areas in which new evidence has …
Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines
WH Geerts, D Bergqvist, GF Pineo, JA Heit… - Chest, 2008 - Elsevier
This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence …
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence …
Development and validation of a predictive model for chemotherapy-associated thrombosis
Risk of venous thromboembolism (VTE) is elevated in cancer, but individual risk factors
cannot identify a sufficiently high-risk group of outpatients for thromboprophylaxis. We …
cannot identify a sufficiently high-risk group of outpatients for thromboprophylaxis. We …
Incidence and predictors of venous thromboembolism (VTE) among ambulatory high‐risk cancer patients undergoing chemotherapy in the United States
AA Khorana, M Dalal, J Lin, GC Connolly - Cancer, 2013 - Wiley Online Library
BACKGROUND: Recent studies suggest that thromboprophylaxis is beneficial in preventing
venous thromboembolism (VTE) in cancer outpatients, but this is not widely adopted …
venous thromboembolism (VTE) in cancer outpatients, but this is not widely adopted …
Assessing risk of venous thromboembolism in the patient with cancer
AA Khorana, GC Connolly - Journal of Clinical Oncology, 2009 - ascopubs.org
Purpose Patients with cancer are increasingly at risk for venous thromboembolism (VTE).
Rates of VTE, however, vary markedly among patients with cancer. Design This review …
Rates of VTE, however, vary markedly among patients with cancer. Design This review …
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer
Purpose To develop guideline recommendations for the use of anticoagulation in the
prevention and treatment of venous thromboembolism (VTE) in patients with cancer …
prevention and treatment of venous thromboembolism (VTE) in patients with cancer …